NO20004089D0 - Nye triazolo(4,5-d)pyrimidinforbindelser - Google Patents

Nye triazolo(4,5-d)pyrimidinforbindelser

Info

Publication number
NO20004089D0
NO20004089D0 NO20004089A NO20004089A NO20004089D0 NO 20004089 D0 NO20004089 D0 NO 20004089D0 NO 20004089 A NO20004089 A NO 20004089A NO 20004089 A NO20004089 A NO 20004089A NO 20004089 D0 NO20004089 D0 NO 20004089D0
Authority
NO
Norway
Prior art keywords
pyrimidine compounds
new triazolo
triazolo
new
pyrimidine
Prior art date
Application number
NO20004089A
Other languages
English (en)
Other versions
NO20004089L (no
Inventor
Roger Brown
Garry Pairaudeau
Brian Springthorpe
Stephen Thom
Paul Willis
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9800458A external-priority patent/SE9800458D0/xx
Priority claimed from SE9803669A external-priority patent/SE9803669D0/xx
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20004089D0 publication Critical patent/NO20004089D0/no
Publication of NO20004089L publication Critical patent/NO20004089L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20004089A 1998-02-17 2000-08-16 Nye triazolo(4,5-d)pyrimidinforbindelser NO20004089L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800458A SE9800458D0 (sv) 1998-02-17 1998-02-17 Novel compounds
SE9803669A SE9803669D0 (sv) 1998-10-26 1998-10-26 Novel compounds
PCT/SE1999/000154 WO1999041254A1 (en) 1998-02-17 1999-02-05 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS

Publications (2)

Publication Number Publication Date
NO20004089D0 true NO20004089D0 (no) 2000-08-16
NO20004089L NO20004089L (no) 2000-10-16

Family

ID=26663214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004089A NO20004089L (no) 1998-02-17 2000-08-16 Nye triazolo(4,5-d)pyrimidinforbindelser

Country Status (21)

Country Link
US (1) US6369064B1 (no)
EP (1) EP1056749B1 (no)
JP (1) JP2002503663A (no)
KR (1) KR20010078696A (no)
CN (1) CN1291193A (no)
AR (1) AR015515A1 (no)
AT (1) ATE232866T1 (no)
AU (1) AU2650099A (no)
BR (1) BR9907934A (no)
CA (1) CA2316264A1 (no)
DE (1) DE69905451T2 (no)
HU (1) HUP0100328A3 (no)
ID (1) ID27127A (no)
IL (1) IL137812A0 (no)
MX (1) MXPA00007634A (no)
NO (1) NO20004089L (no)
NZ (1) NZ505250A (no)
PL (1) PL342430A1 (no)
SK (1) SK12242000A3 (no)
TR (1) TR200002380T2 (no)
WO (1) WO1999041254A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
TWI290549B (en) * 2000-06-02 2007-12-01 Astrazeneca Ab Process for the preparation of cyclopropyl carboxylic acid ester and derivatives
GB0013488D0 (en) 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US7086397B2 (en) * 2002-02-16 2006-08-08 Graham Lindley Spruiell Patient usable emergency medical kit
GB0219746D0 (en) * 2002-08-23 2002-10-02 Inst Of Ex Botany Ascr Azapurine derivatives
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
DE602004027409D1 (de) * 2003-10-21 2010-07-08 Inspire Pharmaceuticals Inc Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (ja) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
JP2010508350A (ja) 2006-10-31 2010-03-18 ヤンセン ファーマシューティカ エヌ．ベー． Ａｄｐｐ２ｙ１２レセプターアンタゴニストとしてのトリアゾロピリミジン誘導体
KR101669297B1 (ko) * 2008-09-09 2016-10-25 아스트라제네카 아베 [1Ｓ-[1-알파,2-알파,3-베타(1Ｓ*,2Ｒ*),5-베타]]-3-[7-[2-(3,4-디플루오로페닐)-사이클로프로필아미노]-5-(프로필티오)-3Ｈ-1,2,3-트리아졸로[4,5-ｄ]피리미딘-3-일]-5-(2-하이드록시에톡시)사이클로펜탄-1,2-디올의 제조 방법 및 그 중간체
WO2015027431A1 (en) 2013-08-29 2015-03-05 Merck Sharp & Dohme Corp. 2,2-difluorodioxolo a2a receptor antagonists
WO2015162630A1 (en) * 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
US9840481B2 (en) 2016-03-22 2017-12-12 Merck Sharp & Dohme Corp. Allosteric modulators of nicotinic acetylcholine receptors
CN111116592A (zh) * 2019-11-27 2020-05-08 杭州沧海帆医药科技有限公司 嘧啶并三氮唑类化合物及其医药用途
CN112876485A (zh) * 2021-01-25 2021-06-01 郭丽伟 一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物
EP4436566A4 (en) * 2021-11-22 2025-07-16 Purdue Research Foundation CELL-POTENT BISUBSTRACT INHIBITORS FOR NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
WO1997003084A1 (en) * 1995-07-11 1997-01-30 Astra Pharmaceuticals Ltd. New inhibitors of platelet aggregation
US6297232B1 (en) * 1996-12-20 2001-10-02 Astrazeneca Ab Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
SE9702774D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
WO1999041254A1 (en) 1999-08-19
US6369064B1 (en) 2002-04-09
KR20010078696A (ko) 2001-08-21
MXPA00007634A (es) 2003-09-10
CA2316264A1 (en) 1999-08-19
ID27127A (id) 2001-03-01
CN1291193A (zh) 2001-04-11
BR9907934A (pt) 2000-10-24
ATE232866T1 (de) 2003-03-15
AR015515A1 (es) 2001-05-02
TR200002380T2 (tr) 2001-03-21
EP1056749A1 (en) 2000-12-06
JP2002503663A (ja) 2002-02-05
HUP0100328A2 (hu) 2001-09-28
SK12242000A3 (sk) 2001-03-12
HUP0100328A3 (en) 2003-04-28
EP1056749B1 (en) 2003-02-19
DE69905451T2 (de) 2003-11-20
NO20004089L (no) 2000-10-16
AU2650099A (en) 1999-08-30
NZ505250A (en) 2002-10-25
PL342430A1 (en) 2001-06-04
IL137812A0 (en) 2001-10-31
DE69905451D1 (de) 2003-03-27

Similar Documents

Publication Publication Date Title
NO20012725L (no) Nye triazolo(4,5-D)pyrimidinforbindelser
DE69918552D1 (de) Pyrrolo(2,3-d)pyrimidin-verbindungen
ATE265458T1 (de) Pyrrolo(2,3-d)pyrimidin-verbindungen
NO20022738L (no) Pyrrolo(2,3-d)pyrimidinforbindelser
ATE284404T1 (de) Pyrazolo(4,3-d)pyrimidinderivate
ATE251161T1 (de) Triazolo(4,5-d)pyrimidin-derivate als antithrombotische mittel
ID27127A (id) SENYAWA-SENYAWA TRIAZOLO (4,5-d) PIRIMIDINA YANG BARU
DE50001191D1 (de) Pyrazolo[4, 3-d]pyrimidine
SI1222195T1 (en) Novel thiazolo(4,5-d)pyrimidine compounds
HK1032589A (en) Novel triazolo(4,5-d)pyrimidine compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application